Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Graft vs Host Disease × ruxolitinib × Clear all

Phase

Phase 2 5 Phase 4 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Thalassemia 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Leukemia, Myeloid, Acute 1 Graft vs Host Disease 1 Epstein-Barr Virus Infections 1 Bronchiolitis Obliterans Syndrome 1

Interventions

ruxolitinib 1 ibrutinib 1 Thiotepa 1 Radiotherapy 1 Panobinostat 1 Filgrastim 1 Cyclophosphamide 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02386800 2026-03-16

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡